Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-16

Clinical Trial Update: LiverTREM-1: Hepatic TREM-1 Expression and Prognosis in Severe Alcoholic Hepatitis

View source ↗

Summary

The trial investigates hepatic TREM-1 expression and its prognostic value in severe alcoholic hepatitis, and it is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Severe Alcoholic Hepatitis | Status: NOT_YET_RECRUITING